Cetuximab + Gemox in Biliary Tract Cancer

NCT01216345 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Unresectable
Locally Advanced
Metastatic

Interventions

DRUG: Cetuximab + Gemcitabine + Oxaliplatin

Sponsor

Association of Research on the Biology of Liver Tumors